FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318473570> ?p ?o ?g. }

• W4318473570 abstract "To evaluate the outcomes and prognostic factors for patients using conversion therapy with lenvatinib combined with transcatheter arterial chemoembolization (TACE) plus programmed cell death protein-1 (PD-1) inhibitors (LTP) for initially unresectable hepatocellular carcinoma (iuHCC).Data on 94 consecutive patients with iuHCC who received LTP conversion therapy from November 2019 to September 2022 were retrospectively analyzed. Early tumor response was reported when patients showed complete or partial response at the time of their first follow-up (4-6 weeks) after initial treatment, in accordance with mRECIST. The endpoints consisted of conversion surgery rate, overall survival (OS), and progression-free survival (PFS).Early tumor response was found in 68 patients (72.3%) and not in the remaining 26 patients (27.7%) in the entire cohort. Early responders had a significantly higher conversion surgery rate than non-early responders (44.1% vs. 7.7%, p=0.001). Early tumor response was the only factor independently associated with successful conversion resection, as indicated by multivariate analysis (OR=10.296; 95% CI: 2.076-51.063; p=0.004). Survival analysis showed that early responders had longer PFS (15.4 vs. 7.8 months, p=0.005) and OS (23.1 vs. 12.5 months, p=0.004) than non-early responders. Early responders who underwent conversion surgery also had significantly longer median PFS and OS (not reached, not reached) than those who did not (11.2 months, p=0.004; 19.4 months, p<0.001). In multivariate analyses, early tumor response was identified as an independent prognostic factor for longer OS (HR=0.404, 95% CI: 0.171-0.954; p=0.039). Successful conversion surgery was also an independent predictive factor for longer PFS (HR=0.248, 95% CI: 0.099-0.622; p=0.003) and OS (HR=0.147, 95% CI: 0.039-0.554; p=0.005).Early tumor response is an important predictive marker for successful conversion surgery and prolonged survival in patients with iuHCC treated using LTP conversion therapy. Conversion surgery is necessary to improve survival during conversion therapy, particularly for early responders." @default.
• W4318473570 created "2023-01-30" @default.
• W4318473570 creator A5007901035 @default.
• W4318473570 creator A5010479652 @default.
• W4318473570 creator A5030177789 @default.
• W4318473570 creator A5046124767 @default.
• W4318473570 creator A5046881277 @default.
• W4318473570 creator A5057292712 @default.
• W4318473570 creator A5064692375 @default.
• W4318473570 creator A5067606924 @default.
• W4318473570 creator A5067855930 @default.
• W4318473570 creator A5075918508 @default.
• W4318473570 creator A5082227652 @default.
• W4318473570 creator A5084056504 @default.
• W4318473570 date "2023-01-30" @default.
• W4318473570 modified "2023-09-30" @default.
• W4318473570 title "Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors" @default.
• W4318473570 cites W1007890594 @default.
• W4318473570 cites W1430632046 @default.
• W4318473570 cites W2023807845 @default.
• W4318473570 cites W2165385913 @default.
• W4318473570 cites W2538328947 @default.
• W4318473570 cites W2581205085 @default.
• W4318473570 cites W2926234449 @default.
• W4318473570 cites W2953751967 @default.
• W4318473570 cites W3012814711 @default.
• W4318473570 cites W3099108820 @default.
• W4318473570 cites W3108220068 @default.
• W4318473570 cites W3137254944 @default.
• W4318473570 cites W3149900842 @default.
• W4318473570 cites W3156872567 @default.
• W4318473570 cites W3195584801 @default.
• W4318473570 cites W3204422329 @default.
• W4318473570 cites W3205914248 @default.
• W4318473570 cites W3212068916 @default.
• W4318473570 cites W4206788213 @default.
• W4318473570 cites W4212772308 @default.
• W4318473570 cites W4220685568 @default.
• W4318473570 cites W4220990811 @default.
• W4318473570 cites W4223902617 @default.
• W4318473570 cites W4224237113 @default.
• W4318473570 cites W4224250169 @default.
• W4318473570 cites W4225310390 @default.
• W4318473570 cites W4232620598 @default.
• W4318473570 cites W4281298900 @default.
• W4318473570 cites W4283793022 @default.
• W4318473570 cites W4296780840 @default.
• W4318473570 doi "https://doi.org/10.3389/fonc.2023.1110689" @default.
• W4318473570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36793614" @default.
• W4318473570 hasPublicationYear "2023" @default.
• W4318473570 type Work @default.
• W4318473570 citedByCount "1" @default.
• W4318473570 countsByYear W43184735702023 @default.
• W4318473570 crossrefType "journal-article" @default.
• W4318473570 hasAuthorship W4318473570A5007901035 @default.
• W4318473570 hasAuthorship W4318473570A5010479652 @default.
• W4318473570 hasAuthorship W4318473570A5030177789 @default.
• W4318473570 hasAuthorship W4318473570A5046124767 @default.
• W4318473570 hasAuthorship W4318473570A5046881277 @default.
• W4318473570 hasAuthorship W4318473570A5057292712 @default.
• W4318473570 hasAuthorship W4318473570A5064692375 @default.
• W4318473570 hasAuthorship W4318473570A5067606924 @default.
• W4318473570 hasAuthorship W4318473570A5067855930 @default.
• W4318473570 hasAuthorship W4318473570A5075918508 @default.
• W4318473570 hasAuthorship W4318473570A5082227652 @default.
• W4318473570 hasAuthorship W4318473570A5084056504 @default.
• W4318473570 hasBestOaLocation W43184735701 @default.
• W4318473570 hasConcept C126322002 @default.
• W4318473570 hasConcept C126894567 @default.
• W4318473570 hasConcept C141071460 @default.
• W4318473570 hasConcept C143998085 @default.
• W4318473570 hasConcept C2776264508 @default.
• W4318473570 hasConcept C2778019345 @default.
• W4318473570 hasConcept C2778695046 @default.
• W4318473570 hasConcept C2780739268 @default.
• W4318473570 hasConcept C3019894029 @default.
• W4318473570 hasConcept C38180746 @default.
• W4318473570 hasConcept C71924100 @default.
• W4318473570 hasConcept C72563966 @default.
• W4318473570 hasConcept C90924648 @default.
• W4318473570 hasConceptScore W4318473570C126322002 @default.
• W4318473570 hasConceptScore W4318473570C126894567 @default.
• W4318473570 hasConceptScore W4318473570C141071460 @default.
• W4318473570 hasConceptScore W4318473570C143998085 @default.
• W4318473570 hasConceptScore W4318473570C2776264508 @default.
• W4318473570 hasConceptScore W4318473570C2778019345 @default.
• W4318473570 hasConceptScore W4318473570C2778695046 @default.
• W4318473570 hasConceptScore W4318473570C2780739268 @default.
• W4318473570 hasConceptScore W4318473570C3019894029 @default.
• W4318473570 hasConceptScore W4318473570C38180746 @default.
• W4318473570 hasConceptScore W4318473570C71924100 @default.
• W4318473570 hasConceptScore W4318473570C72563966 @default.
• W4318473570 hasConceptScore W4318473570C90924648 @default.
• W4318473570 hasLocation W43184735701 @default.
• W4318473570 hasLocation W43184735702 @default.
• W4318473570 hasLocation W43184735703 @default.
• W4318473570 hasOpenAccess W4318473570 @default.
• W4318473570 hasPrimaryLocation W43184735701 @default.
• W4318473570 hasRelatedWork W1978612707 @default.
• W4318473570 hasRelatedWork W2179494416 @default.

• next